Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Pemgarda (pemivibart)
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
Interactions between your drugs
SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine pemivibart
Applies to: sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine, Pemgarda (pemivibart)
If you have recently been vaccinated with SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine, you should not receive pemivibart for at least 14 days. Treatment with pemivibart may reduce the effectiveness of SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine as it could interfere with the vaccine's ability to produce an adequate immune response to the COVID-19 virus. However, you should continue to receive SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine as indicated by local guidelines based on your condition. Pemivibart should not be used as a replacement for SARS-CoV-2 mRNA (tozinameran-tris-sucrose) vaccine. Talk to your doctor or other healthcare providers if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Foscavir
Foscavir is used for CMV Gastroenteritis, CMV Retinitis, herpes simplex ...
Fuzeon
Fuzeon is an antiviral medication used to treat human immunodeficiency virus (HIV). Learn about ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Livtencity
Livtencity (maribavir) is used for post-transplant CMV infection/disease. Includes Livtencity side ...
Prevymis
Prevymis (letermovir) is a prescription antiviral medicine used to prevent cytomegalovirus (CMV) ...
Rukobia
Rukobia (fostemsavir) is used for multidrug-resistant HIV-1 infection. Includes Rukobia side ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.